RSS Items

Gracell Biotechnologies would operate as wholly owned subsidiary under terms of deal

Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss

Shareholder advisory groups say potential £18.7mn payout is excessive

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid-19 jabs

UK pharma group agrees to buy Seattle-based biotech Icosavax

Deal with Absci is the latest between big pharma and tech companies to build new disease treatments

Anglo-Swedish drugmaker targets $80bn in revenue by 2030

Best-selling Tagrisso drug slows progression of most common form of the disease at an early stage

James Muir was discriminated against on the basis of his mental health disability